SEC Company Response from ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052) (AVXL) — Jul 12, 2019

ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052)
Date: July 12, 2019 · CIK: 0001314052 · Accession: 0001213900-19-012578

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-232550

Date

July 12, 2019

Author

/s/ Christopher Missling, PhD

Form

CORRESP

Company

ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052)

Letter

ANAVEX LIFE SCIENCES CORP.

51 W. 52nd Street, 7th Floor

New York, NY 10019-6163

July 12, 2019

VIA EDGAR

United States Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

Attn: Michael Killoy

Re: Anavex Life Sciences Corp.

Request for Acceleration of Registration Statement on Form S-3

File No. 333-232550

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Anavex Life Sciences, Corp., a Nevada corporation (the “Company”), hereby requests acceleration of the effectiveness of its Registration Statement on Form S-3 (File No. 333-232550), filed with the U.S. Securities and Exchange Commission on July 3, 2019, to 4:00 P.M. ET on July 15, 2019 or as soon thereafter as practicable.

Please direct any questions or comments regarding this filing to Clayton Parker, Esq. at (305) 794-6293 of K&L Gates LLP, legal counsel to the Company.

Sincerely,
/s/ Christopher Missling, PhD

Show Raw Text

CORRESP
1
filename1.htm

ANAVEX LIFE SCIENCES CORP.

51 W. 52nd Street, 7th Floor

New York, NY 10019-6163

July 12, 2019

VIA EDGAR

United States Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

Attn: Michael Killoy

    Re:
    Anavex Life Sciences Corp.

    Request for Acceleration of Registration Statement on Form S-3

    File No. 333-232550

Ladies and Gentlemen:

Pursuant to Rule
461 under the Securities Act of 1933, as amended, Anavex Life Sciences, Corp., a Nevada corporation (the “Company”),
hereby requests acceleration of the effectiveness of its Registration Statement on Form S-3 (File No. 333-232550), filed with
the U.S. Securities and Exchange Commission on July 3, 2019, to 4:00 P.M. ET on July 15, 2019 or as soon thereafter as practicable.

Please direct any
questions or comments regarding this filing to Clayton Parker, Esq. at (305) 794-6293 of K&L Gates LLP, legal counsel to the
Company.

    Sincerely,

        /s/ Christopher Missling, PhD

        Christopher Missling, PhD

        Chief Executive Officer

SecProbe.io